646 related articles for article (PubMed ID: 12405864)
21. [Therapeutic drug monitoring and individual dosing of antibiotics during sepsis : Modern or just "trendy"?].
Brinkmann A; Röhr AC; Köberer A; Fuchs T; Preisenberger J; Krüger WA; Frey OR
Med Klin Intensivmed Notfmed; 2018 Mar; 113(2):82-93. PubMed ID: 27624768
[TBL] [Abstract][Full Text] [Related]
22. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
Baudo F; de Cataldo F
Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
[TBL] [Abstract][Full Text] [Related]
23. The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents.
Blot SI; Pea F; Lipman J
Adv Drug Deliv Rev; 2014 Nov; 77():3-11. PubMed ID: 25038549
[TBL] [Abstract][Full Text] [Related]
24. [Effect of catecholamines on splanchnic perfusion in sepsis].
Hernández G; Tomicic V
Rev Med Chil; 1999 Jun; 127(6):719-27. PubMed ID: 10513083
[TBL] [Abstract][Full Text] [Related]
25. Effects of hypothermia on pharmacokinetics and pharmacodynamics: a systematic review of preclinical and clinical studies.
van den Broek MP; Groenendaal F; Egberts AC; Rademaker CM
Clin Pharmacokinet; 2010 May; 49(5):277-94. PubMed ID: 20384391
[TBL] [Abstract][Full Text] [Related]
26. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update.
Morgan DJ; McLean AJ
Clin Pharmacokinet; 1995 Nov; 29(5):370-91. PubMed ID: 8582120
[TBL] [Abstract][Full Text] [Related]
27. Clinical pharmacology of bosentan, a dual endothelin receptor antagonist.
Dingemanse J; van Giersbergen PL
Clin Pharmacokinet; 2004; 43(15):1089-115. PubMed ID: 15568889
[TBL] [Abstract][Full Text] [Related]
28. Oxygen extraction and perfusion markers in severe sepsis and septic shock: diagnostic, therapeutic and outcome implications.
Rivers EP; Yataco AC; Jaehne AK; Gill J; Disselkamp M
Curr Opin Crit Care; 2015 Oct; 21(5):381-7. PubMed ID: 26348417
[TBL] [Abstract][Full Text] [Related]
29. High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications.
Wu A; Hinds CJ; Thiemermann C
Shock; 2004 Mar; 21(3):210-21. PubMed ID: 14770033
[TBL] [Abstract][Full Text] [Related]
30. The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.
Mitani GM; Steinberg I; Lien EJ; Harrison EC; Elkayam U
Clin Pharmacokinet; 1987 Apr; 12(4):253-91. PubMed ID: 3297463
[TBL] [Abstract][Full Text] [Related]
31. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic drug interactions with phenytoin (Part I).
Nation RL; Evans AM; Milne RW
Clin Pharmacokinet; 1990 Jan; 18(1):37-60. PubMed ID: 2178849
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic drug interactions in anaesthetic practice.
Wood M
Clin Pharmacokinet; 1991 Oct; 21(4):285-307. PubMed ID: 1760901
[TBL] [Abstract][Full Text] [Related]
34. Glucocorticoid administration in sepsis and septic shock: time for a paradigm change?
Antonucci E; Fiaccadori E; Taccone FS; Vincent JL
Minerva Anestesiol; 2014 Sep; 80(9):1058-62. PubMed ID: 24971687
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies.
Pentel P; Benowitz N
Clin Pharmacokinet; 1984; 9(4):273-308. PubMed ID: 6380870
[TBL] [Abstract][Full Text] [Related]
36. Clinical pharmacokinetics in heart failure. An updated review.
Shammas FV; Dickstein K
Clin Pharmacokinet; 1988 Aug; 15(2):94-113. PubMed ID: 3064953
[TBL] [Abstract][Full Text] [Related]
37. Impact of appropriate antimicrobial therapy for patients with severe sepsis and septic shock--a quality improvement study.
Yokota PK; Marra AR; Martino MD; Victor ES; Durão MS; Edmond MB; dos Santos OF
PLoS One; 2014; 9(11):e104475. PubMed ID: 25375775
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.
Lamp KC; Freeman CD; Klutman NE; Lacy MK
Clin Pharmacokinet; 1999 May; 36(5):353-73. PubMed ID: 10384859
[TBL] [Abstract][Full Text] [Related]
39. Effect of hepatic insufficiency on pharmacokinetics and drug dosing.
Verbeeck RK; Horsmans Y
Pharm World Sci; 1998 Oct; 20(5):183-92. PubMed ID: 9820880
[TBL] [Abstract][Full Text] [Related]
40. The impact of sepsis on hepatic drug metabolism in critically ill patients: a narrative review.
Ewoldt TM; Abdulla A; Hunfeld N; Li L; Smeets TJL; Gommers D; Koch BCP; Endeman H
Expert Opin Drug Metab Toxicol; 2022 Jun; 18(6):413-421. PubMed ID: 35912845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
